Distinct influences of nicotine and sensorimotor stimuli on reducing cravings to smoke and vape among dual users.
Population Clinical
Cessation
Palmer (2021)
Interest in quitting e-Cigarettes among adult e-Cigarette Users With and Without Cigarette Smoking history.
Population Clinical
Cessation
ENDS
Palmer (2021)
Interest in quitting e-cigarette use by device type and smoking history in US adults.
Population Clinical
Cessation
ENDS
Palmer (2023)
Evaluation of Second-hand Exposure to Electronic Cigarette Vaping under a Real Scenario: Measurements of Ultrafine Particle Number Concentration and Size Distribution and Comparison with Traditional Tobacco Smoke.
Nonclinical
Chemical
Analysis
Palmisani (2019)
Urinary Cotinine and Nicotine Dependence Levels in Regular Male Electronic Cigarette Users.
Individual Clinical
Biomarkers
Biomarkers Of Exposure
Pamungkasninhsih (2021)
Electronic cigarette use among adults in 14 countries: a cross-sectional study.
Individual Clinical
User Topography
Pan (2022)
Lactate Dehydrogenase Levels in the Saliva of Cigarette and E-Cigarette Smokers (Vapers): a Comparative analysis.
Individual Clinical
Biomarkers
Biomarkers Of Exposure
Pandarathodiyil (2021)
Sex differences in the appeal of flavored e-cigarettes among young adult e-cigarette users.
Population Clinical
Consumer Use
Flavor Appeal
Pang (2020)
Parsing Intra- and Inter-Individual Covariation Between the Sensory attributes and appeal of E-Cigarettes: associations and Gender Differences.
Population Clinical
Consumer Use
Factors Influencing Patterns Of Use
Pang (2022)
Calculated Cancer Risks for Conventional and “Potentially Reduced Exposure Product” Cigarettes
Nonclinical
Carcinogenicity
Pankow (2007)